Dexcom DXCM recently announced an upcoming nationwide rollout of an AI-driven upgrade to its Stelo platform aimed at ...
This is now a Class I recall, meaning that the use of these continuous glucose monitoring systems could cause serious health ...
Zacks Investment Research on MSN
DexCom (DXCM) is a top-ranked growth stock: Should you buy?
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
Dexcom (NSDQ:DXCM) announced today that it plans to launch an advanced AI-enabled enhancement to its Stelo over-the-counter ...
Southeast Asia Medical Wearable Devices Market was valued at ~USD 2,080.65 million in 2024 grow at a strong CAGR of ...
In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...
Apple Watch now supports glucose monitoring via CGMs like Dexcom G7, while Apple continues long-term work on non-invasive blood sugar tracking.
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 ...
DexCom reported strong preliminary Q4 results, with topline figures above its earlier expectations. The company paired this ...
DexCom recently reported preliminary fourth-quarter results showing year-over-year revenue growth in both U.S. and ...
DexCom Inc (NASDAQ:DXCM) is one of the 12 best Medical Devices stocks to invest in according to Hedge Funds. As of the ...
The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results